Latest in Science

Image credit:

Bionic eye closer to human trials with invention of implantable microchip

Share
Tweet
Share

Sponsored Links

We've had our eye -- so to speak -- on Bionic Vision Australia (BVA) for sometime, and with the invention of a new implantable microchip it's coming ever closer to getting the bionic eye working on real-deal humans. The tiny chip measures five square millimeters and packs 98 electrodes that stimulate retinal cells to restore vision. Preliminary tests are already underway, and clinicians are in the process of screening human guinea pigs for sampling the implants -- the first full system is still on track for a 2013 debut. In the interest of future success: here's mud in your eye, BVA! Full PR after the break.


Show full PR text
Major advance for bionic eye

UNSW researchers have unveiled the microchip which is expected to power Australia's first bionic eye.

Associate Professor Gregg Suaning, of the Graduate School of Biomedical Engineering and a project leader in the national bionic eye consortium, Bionic Vision Australia (BVA), said the new, 98-channel microchip, now undergoing preliminary lab testing, was a major step towards the goal of a functional bionic eye.

"This is a remarkable new microchip that has brought an Australian retinal implant much closer to reality," he said.

"At only five square millimetres, the device is tiny but represents a significant advance in nerve stimulation technology. The design team incorporated never-before attempted features with this design and they absolutely nailed every aspect. The result is mind boggling."

BVA Director, Professor Anthony Burkitt, said the production of the chip, a year after BVA received funding for the bionic eye project, represented "a major advance in technology".

"This microchip is at the heart of the retinal implant, which stimulates the retinal cells to elicit vision. It is an important component in the development of our first bionic vision system that may provide real, functional benefits for patients and make our technology competitive internationally," he said.

The microchip is performing well in preliminary lab testing. It will be at the core of the Wide-View neurostimulator device being developed by BVA, with the first full implant of the system in a patient planned for 2013.














All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
Share
Tweet
Share

Popular on Engadget

The 2020 Engadget Holiday Gift Guide

The 2020 Engadget Holiday Gift Guide

View
macOS Big Sur review: A mix of new and familiar

macOS Big Sur review: A mix of new and familiar

View
All Warner Bros. films in 2021 will debut on HBO Max

All Warner Bros. films in 2021 will debut on HBO Max

View
The gold, 8th-generation iPad returns to $299 at Amazon

The gold, 8th-generation iPad returns to $299 at Amazon

View
DoorDash lets restaurants add their own delivery drivers to its service

DoorDash lets restaurants add their own delivery drivers to its service

View

From around the web

Page 1Page 1ear iconeye iconFill 23text filevr